Search

everythinglearnresearchcommunity

for

Search:↓

Seborrheic dermatitis lowers quality of life more for women, younger people, and those with more education.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Ketoconazole cream is effective for skin conditions like seborrheic dermatitis and may help with hair loss and other skin issues, with generally mild side effects.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

The Egyptian Arabic Skindex-16 is a reliable way to measure how skin diseases affect quality of life in Egyptian patients.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

Alopecia areata and androgenetic alopecia affect quality of life similarly.

Skin health and diseases are closely linked to metabolic processes.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

The document concludes that various hair and scalp disorders in children have specific treatments and proper diagnosis is essential.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

People with alopecia areata often have lower vitamin D levels than healthy people.

Clinicians should look for skin issues, sleep problems, cognitive changes, and food cravings as signs of insulin resistance.

Being overweight, having gallbladder removal surgery, and taking cholesterol-lowering drugs are linked to a higher chance of getting vulvar lichen sclerosus.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Baricitinib is effective and safe for treating severe alopecia areata.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Seborrheic dermatitis significantly lowers quality of life, especially in young people, women, and those with higher education.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Low PON1 levels may indicate and predict the severity of hair loss.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Obesity is linked to skin conditions like acanthosis nigricans and skin tags, which may indicate high insulin levels.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.